Skip to main content

Day: November 12, 2025

Apache Creek Golf Club Completes Strategic Course and Facility Enhancements to Elevate Guest Experience and Asset Value

Written by Customer Service on . Posted in Public Companies.

APACHE JUNCTION, Ariz., Nov. 12, 2025 (GLOBE NEWSWIRE) — The Marquie Group, Inc. (“TMGI” or the “Company”) (OTCID:TMGI) today publicly announced that its subsidiary, Apache Creek Golf Club, one of Arizona’s premier true desert golf destinations, has completed a series of strategic investments in its course and facilities designed to strengthen its market position and enhance long-term value. The club recently completed its annual overseeding process, ensuring optimal playing conditions and a consistently high-quality experience for golfers year-round. This meticulous attention to detail underscores Apache Creek’s commitment to operational excellence and customer satisfaction – both on and off the course. Furthering its investment in guest amenities, Apache Creek has unveiled a newly redesigned Pro Shop, now offering an expanded...

Continue reading

Actelis Networks Secures New Order from Major Central German Utility Provider for Cyber-Hardened Distribution Network Connectivity

Written by Customer Service on . Posted in Public Companies.

Encrypted Networking Solutions to Secure Critical Water, Gas and Electricity Infrastructure FREMONT, Calif, Nov. 12, 2025 (GLOBE NEWSWIRE) — Actelis Networks, Inc. (NASDAQ: ASNS) (“Actelis” or the “Company”), a market leader in cyber-hardened, rapid deployment networking solutions for IoT and broadband applications, today announced it has secured a new order from one of the largest regional utility companies in Central Germany to provide cyber-hardened, rapid deployment networking solutions for its distribution infrastructure. The utility provider, which serves critical water, gas and electricity distribution services across the region, selected Actelis to connect its distribution network with fiber-grade performance and military-grade encryption. The solution’s encryption capabilities were instrumental...

Continue reading

Suntex Enterprises Inc. (OTC: SNTX) Achieves OTCID Verified Status and Appoints Javier Leal as Chief Executive Officer to Lead Major Corporate Advancements

Written by Customer Service on . Posted in Public Companies.

LAS VEGAS, Nov. 12, 2025 (GLOBE NEWSWIRE) — via IBN — Suntex Enterprises Inc. is pleased to announce that it has achieved OTCID Verified status on OTC Markets and has officially appointed Javier Leal as its new Chief Executive Officer. These actions mark the beginning of a comprehensive corporate restructuring and expansion initiative designed to position Suntex for accelerated growth and long-term shareholder value creation. Under Mr. Leal’s leadership, the Company is executing a defined operational roadmap focused on compliance, governance, and the acquisition of revenue-producing assets. The appointment follows a series of strategic internal developments that have strengthened the Company’s foundation ahead of multiple key announcements anticipated in Q4. “This milestone represents more than an administrative upgrade—it...

Continue reading

PharmaCorp Announces Closing of C$23 Million Bought Deal Public Offering

Written by Customer Service on . Posted in Public Companies.

NOT FOR DISTRIBUTION TO UNITED STATES NEWS WIRE SERVICES OR FOR DISSEMINATION IN THE UNITED STATES CALGARY, Alberta, Nov. 12, 2025 (GLOBE NEWSWIRE) — PHARMACORP RX INC. – PharmaCorp Rx Inc. (“PharmaCorp” or the “Company”) (TSXV: PCRX) is pleased to announce that it has closed its previously announced bought deal public offering co-led by Canaccord Genuity Corp. and Acumen Capital Finance Partners Limited, and including Raymond James Ltd., iA Private Wealth Inc., and Bloom Burton Securities Inc. (the “Underwriters”) pursuant to which the Underwriters purchased, on a bought deal basis, 54,855,000 units (the “Units”) in the capital of the Company at a price of C$0.42 per Unit (the “Offering Price”) for aggregate gross proceeds to the Company of approximately C$23.0 million, which includes the full exercise of the over-allotment option...

Continue reading

All Better Pediatrics is Now Part of Zarminali Pediatrics, Bringing Future of Care to Tennessee Families

Written by Customer Service on . Posted in Mergers And Acquisitions.

Dr. Tamara Folz and her Memphis-based team have joined the national pediatric network and become the first of Zarminali’s clinics in Tennessee MEMPHIS, Nov. 12, 2025 (GLOBE NEWSWIRE) — Zarminali Pediatrics, the first outpatient pediatric destination purpose-built to provide elevated, seamlessly coordinated primary and specialty care nationwide, announced that All Better Pediatrics has joined its growing network. Now operating as Zarminali Pediatrics, the practice is Zarminali’s first in Tennessee and aims to bring care experiences built on compassion and coordination to families in the Memphis area. “All Better Pediatrics has long been dedicated to individualized care for generations of families. The relationships we’ve built with patients and families are at the heart of everything we do, and it’s been a privilege to be part of...

Continue reading

EV Realty Secures Additional Investment from Outpost, a GreenPoint Portfolio Company, Adds to Real Estate Portfolio with Stockton Property Acquisition

Written by Customer Service on . Posted in Mergers And Acquisitions.

Strategic investments will help the company address fleet needs through a growing network of charging hubs SAN FRANCISCO, Nov. 12, 2025 (GLOBE NEWSWIRE) — EV Realty announced today that Outpost, a GreenPoint portfolio company, has contributed assets for a direct minority investment in the company. This additional investment positions EV Realty to continue scaling its Powered Properties® portfolio to enable trucking fleet electrification along key freight corridors. As part of this effort, EV Realty also announced it has acquired an industrial property in Stockton, California that is ideally located for freight and logistics operations in a rapidly growing, power constrained region central to trucking operations in Northern California. “EV Realty, our investors, and our project partners continue to see compelling opportunities to...

Continue reading

Silexion Therapeutics Reports Third Quarter 2025 Financial Results and Provides Business Update

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Continued advancement toward Phase 2/3 clinical trial initiation, on track for the first half of 2026 New preclinical data demonstrated SIL204’s exceptional efficacy across multiple human cancer cell lines, highlighting potential effectiveness against five KRAS-driven cancer types Successfully raised over $9 million during the third quarter, significantly strengthening the Company’s balance sheet Grand Cayman, Cayman Islands, Nov. 12, 2025 (GLOBE NEWSWIRE) — Silexion Therapeutics Corp. (NASDAQ: SLXN) (“Silexion” or the “Company”), a clinical-stage biotechnology company developing RNA interference (RNAi) therapies for KRAS-driven cancers, today reported its financial results for the third quarter ended September 30, 2025, and provided an update on recent business developments. Recent Milestones & Business...

Continue reading

Qualstar Corporation Reports Third Quarter 2025 Results

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

Quarterly Revenue Up 49% Year-over-Year Positioned to Capitalize on Tape Storage Resurgence and Data Growth Megatrend Debt-Free, Profitable, and Uplisting-Ready with Expanding Strategic Opportunities CAMARILLO, Calif., Nov. 12, 2025 (GLOBE NEWSWIRE) — Qualstar Corporation (OTC: QBAK), a trusted provider of scalable data storage and high-efficiency power solutions, today reported financial results for the third quarter ended September 30, 2025. The third quarter of 2025 reflected strong execution and accelerating demand for Qualstar’s tape-storage systems. With no debt, consistent profitability, and growing visibility across global customers and partners, Qualstar is well-positioned to scale both organically and through strategic initiatives as the data-storage industry enters a new era of growth. Third Quarter 2025 Financial HighlightsRevenue...

Continue reading

Connect Biopharma Reports Third Quarter 2025 Financial Results and Provides Business Update

Written by Customer Service on . Posted in Earnings Releases And Operating Results.

– Recruitment ongoing for Phase 2 Seabreeze STAT studies for acute exacerbations in asthma and COPD; expect to report topline data from both studies in 1H26 – – New Drug Application for rademikibart for the treatment of atopic dermatitis submitted by Simcere, the Company’s exclusive licensee in Greater China, was accepted by China’s NMPA – – Completed termination of American Depositary Receipt program and directly listed our ordinary shares on Nasdaq – – Presented positive data at ERS 2025 supporting the potential of rademikibart to deliver differentiated efficacy and safety in patients across a broad range of baseline type 2 inflammatory markers – SAN DIEGO, Nov. 12, 2025 (GLOBE NEWSWIRE) — Connect Biopharma Holdings Limited (Nasdaq: CNTB) (Connect Biopharma, Connect or the Company), a clinical-stage biopharmaceutical company...

Continue reading

Most Executives Say Ignoring AI Is a Bigger Threat to Your Career Than the Tech Itself

Written by Customer Service on . Posted in Public Companies.

Kelly® Global Re:work Report shows adoption stalls without trust, training, defined benefits for workers TROY, Mich., Nov. 12, 2025 (GLOBE NEWSWIRE) — Senior executives across industries view acquiring AI skills as essential to long-term career success while many employees remain unconvinced, according to a new survey from leading specialty talent solutions provider Kelly (Nasdaq: KELYA, KELYB). The Kelly Global Re:work Report reveals nearly seven in ten executives (69%) believe refusing to adopt AI is a greater threat to someone’s job than the technology itself, and more than half (59%) say they would replace workers who resist adopting these tools. Executives say AI should free up time for employees to focus on high-value tasks like collaboration, mentoring, and knowledge-sharing. However, fewer than half of workers (47%) report...

Continue reading

Disclaimer & Cookie Notice

Welcome to GOLDEA services for Professionals

Before you continue, please confirm the following:

Professional advisers only

I am a professional adviser and would like to visit the GOLDEA CAPITAL for Professionals website.

Important Notice for Investors:

The services and products offered by Goldalea Capital Ltd. are intended exclusively for professional market participants as defined by applicable laws and regulations. This typically includes institutional investors, qualified investors, and high-net-worth individuals who have sufficient knowledge, experience, resources, and independence to assess the risks of trading on their own.

No Investment Advice:

The information, analyses, and market data provided are for general information purposes only and do not constitute individual investment advice. They should not be construed as a basis for investment decisions and do not take into account the specific investment objectives, financial situation, or individual needs of any recipient.

High Risks:

Trading in financial instruments is associated with significant risks and may result in the complete loss of the invested capital. Goldalea Capital Ltd. accepts no liability for losses incurred as a result of the use of the information provided or the execution of transactions.

Sole Responsibility:

The decision to invest or not to invest is solely the responsibility of the investor. Investors should obtain comprehensive information about the risks involved before making any investment decision and, if necessary, seek independent advice.

No Guarantees:

Goldalea Capital Ltd. makes no warranties or representations as to the accuracy, completeness, or timeliness of the information provided. Markets are subject to constant change, and past performance is not a reliable indicator of future results.

Regional Restrictions:

The services offered by Goldalea Capital Ltd. may not be available to all persons or in all countries. It is the responsibility of the investor to ensure that they are authorized to use the services offered.

Please note: This disclaimer is for general information purposes only and does not replace individual legal or tax advice.